Skip to main content

Table 9 Outcomes predicted by models for one birth cohort in Amr- region

From: Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world

 

POLYMODa

Roxanne

CoRoVa

Undiscounted cases

   

   Mild

8,989

11,318

12,481

   Moderate

4,760

6,471

5,286

   Severe

496

897

514

   Nosocomial

164

193

263

   Deaths

31

59

50

   Outpatient

5,256

6,471

5,286

   Inpatient (comm. acq.)

496

897

514

Discounted savings

   

   Outpatient

$181,333

$216,626

$239,534

   Inpatient

$330,083

$432,618

$255,186

   Indirect

$105,467

$98,697

$78,947

Discounted net costsb (*1000)

$293

$ 346-1,127

$ 495-1271

Discounted QALYs

   

   Mortality

900

1,662

1,413

   Morbidity

53

66

61

  1. a. Approximations for one cohort from the multi-cohort results; b. Health-care perspective and range given for previous upper and lower vaccine prices if appropriate
Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us